Specialist in nephrology, oncology and immunology
Regional office for a Japanese pharmaceutical company in Dubai
Amin Al-Amiri: "International companies in the UAE support 41 countries, supplying them with medicines from their logistical warehouses in Dubai."
The Assistant Undersecretary of the Ministry of Health for the Public Health and Licensing Sector, Dr. Amin Hussain Al-Amiri, inaugurated in Dubai Medical City the new scientific regional headquarters of the Japanese company, Kiowa Kirin, which specializes in the field of kidney diseases, oncology and immunology, bringing the number of scientific offices in the country to 78, simultaneously. With expectations of reaching 85, at the end of next year.
Al-Amiri pointed out that the UAE represents an ideal destination for global pharmaceutical companies, with the aim of operating and managing their operations across the region, given its strong commercial infrastructure, in addition to the organizational facilities it provides to companies, which have contributed to creating a package of attractive investment opportunities for pharmaceutical companies, and created an atmosphere It is competitive, pointing out that the opening of Kiowa Kirin its regional office in the UAE provides many opportunities for Japanese pharmaceutical companies to invest in the UAE and the region, adding that international companies in the UAE support nearly 41 countries, providing them with medicines from their logistical stores in Dubai specifically.
Al-Amiri stressed the Ministry of Health and Community Protection’s keenness to strengthen the strategic partnership in the pharmaceutical sector with international companies producing the drug, to provide the best treatment for patients, and to support the pharmaceutical economy system in the UAE, in line with the Ministry’s strategy aimed at providing comprehensive and innovative health care to members of society, according to the highest standards. Globalism.
For his part, Director of Kiowa Kirin Corporation, Toshifumi Mikayama, said that launching the company's operations in the United Arab Emirates reflects the image of the company's global expansion efforts, and aims to harness its energies to create new value necessary for sustainable growth, stressing the company's commitment to investing in the country and the region. And its keenness to develop a strong partnership with the Ministry of Health, by transferring expertise and innovations in many therapeutic fields.
The head of the global markets of Kiwa Kirin, Abdul Molek, said that the United Arab Emirates is a model to be followed in attracting international companies, given the ease of business in it, excellent infrastructure, good quality of life and openness. Our primary goal at Kiowa Kirin is to create value for patients, by striving for advances in life science and technology, and we look forward to expanding our operations across the region, to help meet medical needs.
The Ministry of Health is looking forward to increasing the number of scientific offices in the country to 85 by 2021